Primary central nervous system lymphoma and glioblastoma: differentiation using dynamic susceptibility-contrast perfusion-weighted imaging, diffusion-weighted imaging, and (18)F-fluorodeoxyglucose positron emission tomography.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Clinical imaging

• Publication date

  2015-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.clinimag.2014.12.002PMID 25547624
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Brain Tumors

  2019cited by this paper
• Recurrent glioblastoma treated with bevacizumab: contrast-enhanced T1-weighted subtraction maps improve tumor delineation and aid prediction of survival in a multicenter clinical trial.

  2014cited by this paper
• The diagnostic role of 18F-FDG PET for primary central nervous system lymphoma

  2014cited by this paper
• Primary central nervous system lymphoma and atypical glioblastoma: multiparametric differentiation by using diffusion-, perfusion-, and susceptibility-weighted MR imaging.

  2014cited by this paper
• r ecurrent glioblastoma Treated with Bevacizumab: Contrast- enhanced T1-weighted Subtraction Maps Improve Tumor Delineation and Aid Prediction of Survival in a

  2014cited by this paper
• Differentiation of Primary Central Nervous System Lymphomas and Glioblastomas: Comparisons of Diagnostic Performance of Dynamic Susceptibility Contrast-Enhanced Perfusion MR Imaging without and with Contrast-Leakage Correction

  2013influential reference
• Differentiation of true progression from pseudoprogression in glioblastoma treated with radiation therapy and concomitant temozolomide: comparison study of standard and high-b-value diffusion-weighted imaging.

  2013cited by this paper
• The 39 steps: evading error and deciphering the secrets for accurate dynamic susceptibility contrast MRI

  2013cited by this paper
• Relation between FDG uptake and apparent diffusion coefficients in glioma and malignant lymphoma

  2012cited by this paper
• Lymphomas and glioblastomas: differences in the apparent diffusion coefficient evaluated with high b-value diffusion-weighted magnetic resonance imaging at 3T.

  2012cited by this paper
• Differentiation of Newly Diagnosed Glioblastoma Multiforme and Intracranial Diffuse Large B-cell Lymphoma Using 11C-Methionine and 18F-FDG PET

  2012cited by this paper
• Does adding FDG-PET to MRI improve the differentiation between primary cerebral lymphoma and glioblastoma? Observer performance study

  2011cited by this paper
• Current management of primary central nervous system lymphoma.

  2010cited by this paper
• Primary central nervous system lymphoma: Immunohistochemical profile and prognostic significance

  2009cited by this paper
• Primary central nervous system lymphoma.

  2008cited by this paper
• 18F-FDG PET of common enhancing malignant brain tumors.

  2008cited by this paper
• WHO Classification of Tumours of the Central Nervous System. 4th Ed.

  2007cited by this paper
• Angiogenesis in brain tumours

  2007cited by this paper
• WHO classification of tumours of the central nervous system

  2007cited by this paper
• Molecular pathogenesis of primary central nervous system lymphoma.

  2006cited by this paper
• Relative cerebral blood volume maps corrected for contrast agent extravasation significantly correlate with glioma tumor grade, whereas uncorrected maps do not.

  2006cited by this paper
• Perfusion and diffusion MR imaging in enhancing malignant cerebral tumors.

  2006cited by this paper
• Correlation of computed tomography with the histopathology of primary malignant lymphoma of the brain

  2004cited by this paper
• Imaging gliomas with positron emission tomography and single-photon emission computed tomography.

  2003cited by this paper
• Distinguishing of primary cerebral lymphoma from high-grade glioma with perfusion-weighted magnetic resonance imaging.

  2003cited by this paper
• The continuing increase in the incidence of primary central nervous system non‐Hodgkin lymphoma

  2002cited by this paper
• Lymphomas and high-grade astrocytomas: comparison of water diffusibility and histologic characteristics.

  2002cited by this paper
• Treatment of malignant glioma: a problem beyond the margins of resection

  2001cited by this paper
• Brain tumors.

  2001cited by this paper
• The blood-brain barrier in primary CNS lymphomas: ultrastructural evidence of endothelial cell death.

  1999cited by this paper
• Angiogenesis in brain tumors; pathobiological and clinical aspects

  1997cited by this paper
• Primary central nervous system lymphoma: radiologic-pathologic correlation.

  1997cited by this paper
• Image thresholding by minimizing the measures of fuzzines

  1995cited by this paper
• Studies of primary central nervous system lymphoma with fluorine-18-fluorodeoxyglucose positron emission tomography.

  1992cited by this paper
• [Malignant lymphomas].

  1985cited by this paper

• 68Ga-Pentixafor PET in Combination With MRI Improves the Differential Diagnosis of Glioblastoma and Primary Central Nervous System Lymphoma

  2025cites this paper
• Primary brain lymphoma and glioblastoma: evaluation of DCE T1 and DSC T2 MRI perfusion findings

  2024cites this paper
• Differentiating IDH-mutant astrocytomas and 1p19q-codeleted oligodendrogliomas using DSC-PWI: high performance through cerebral blood volume and percentage of signal recovery percentiles

  2024cites this paper
• Differentiating glioblastoma from primary central nervous system lymphoma of atypical manifestation using multiparametric magnetic resonance imaging: A comparative study.

  2023cites this paper
• Role of Advanced MR Imaging in Diagnosis of Neurological Malignancies: Current Status and Future Perspective.

  2023cites this paper
• Can we distinguish atypical primary brain lymphoma from glioblastoma multiforme by looking at the non-enhancing tumor?

  2023cites this paper
• Atypical primary central nervous system lymphoma and glioblastoma: multiparametric differentiation based on non-enhancing volume, apparent diffusion coefficient, and arterial spin labeling

  2023cites this paper
• Use of 18F-FDG-PET/CT in differential diagnosis of primary central nervous system lymphoma and high-grade gliomas: A meta-analysis

  2022cites this paper
• Progress of radiological-pathological workflows in the differential diagnosis between primary central nervous system lymphoma and high-grade glioma

  2022cites this paper
• Challenges and opportunities for advanced neuroimaging of glioblastoma

  2022cites this paper
• Diagnostic Accuracy of the Diffusion-Weighted Imaging Method Used in Association With the Apparent Diffusion Coefficient for Differentiating Between Primary Central Nervous System Lymphoma and High-Grade Glioma: Systematic Review and Meta-Analysis

  2022cites this paper
• Primary hypothalamic lymphoma with clinical findings mimicking pituitary apoplexy: a case report

  2021cites this paper
• Differentiation between primary CNS lymphoma and atypical glioblastoma according to major genomic alterations using diffusion and susceptibility-weighted MR imaging.

  2021cites this paper
• Differentiation of Primary CNS lymphoma and High-grade glioma with Dynamic Susceptibility Contrast derived metrics: A Pilot Study.

  2021cites this paper
• The Additional Value of 18F-FDG PET and MRI in Patients with Glioma: A Review of the Literature from 2015 to 2020

  2020cites this paper
• Differential diagnosis of central lymphoma and high-grade glioma: dynamic contrast-enhanced histogram

  2020influential citation
• Brain MRI with Quantitative Susceptibility Mapping: Relationship to CT Attenuation Values.

  2020cites this paper
• MRI Perfusion Techniques

  2020cites this paper
• Diagnostic Performance of Pretreatment 18F-Fluorodeoxyglucose Positron Emission Tomography With or Without Computed Tomography in Patients With Primary Central Nervous System Lymphoma: Updated Systematic Review and Diagnostic Test Accuracy Meta-analyses.

  2020cites this paper
• Diagnostic performance of DWI for differentiating primary central nervous system lymphoma from glioblastoma: a systematic review and meta-analysis

  2019cites this paper
• In vivo measurement of cytoplasmic organelle water fraction using diffusion-weighted imaging

  2019cites this paper
• MRI as a diagnostic biomarker for differentiating primary central nervous system lymphoma from glioblastoma: A systematic review and meta‐analysis

  2019cites this paper
• Accuracy of apparent diffusion coefficients and enhancement ratios on magnetic resonance imaging in differentiating primary cerebral lymphomas from glioblastoma

  2019cites this paper
• New MR perfusion features in primary central nervous system lymphomas: pattern and prognostic impact

  2018cites this paper
• Multiparametric imaging-based differentiation of lymphoma and glioblastoma: using T1-perfusion, diffusion, and susceptibility-weighted MRI.

  2018cites this paper
• Primary CNS Lymphomas: Challenges in Diagnosis and Monitoring

  2018influential citation
• Differentiating between Glioblastoma and Primary CNS Lymphoma Using Combined Whole-tumor Histogram Analysis of the Normalized Cerebral Blood Volume and the Apparent Diffusion Coefficient

  2018cites this paper
• Accuracy of Susceptibility-Weighted Imaging and Dynamic Susceptibility Contrast Magnetic Resonance Imaging for Differentiating High-Grade Glioma from Primary Central Nervous System Lymphomas: Meta-Analysis.

  2018cites this paper
• Differentiation between Glioblastoma and Primary Central Nervous System Lymphoma Using Dynamic Susceptibility Contrast-Enhanced Perfusion MR Imaging: Comparison Study of the Manual versus Semiautomatic Segmentation Method

  2017cites this paper
• Differentiation of Glioblastoma and Lymphoma Using Feature Extraction and Support Vector Machine.

  2017cites this paper
• Differentiating Between Primary Central Nervous System Lymphomas and Glioblastomas: Combined Use of Perfusion-Weighted and Diffusion-Weighted Magnetic Resonance Imaging.

  2017cites this paper
• The performance of MR perfusion-weighted imaging for the differentiation of high-grade glioma from primary central nervous system lymphoma: A systematic review and meta-analysis

  2017cites this paper
• Diagnostic utility of FDG-PET in neurolymphomatosis: report of five cases

  2016cites this paper
• T1-weighted MR imaging of glioma at 3T: a comparative study of 3D MPRAGE vs. conventional 2D spin-echo imaging.

  2016cites this paper